Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

6.68
Delayed Data
As of 3:59pm ET
 +0.01 / +0.15%
Today’s Change
4.11
Today|||52-Week Range
8.38
+13.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues7.0M10.8M13.7M32.0M
 
 
 
 
 
Cost of Goods Sold--495.0K6.6M66.3M
 
 
 
 
Depreciation And Amortization54.0K306.0K596.0K1.0M
 
 
 
 
 
 
Operating ExpensesGross Income--10.0M6.4M-35.3M
 
 
 
 
General Expenses53.0M121.3M117.5M113.1M
 
 
 
 
 
Other Operating Expenses0.000.000.00-25.6M
 
 
Research And Development33.7M51.4M36.6M29.5M
 
 
 
 
 
Total Operating Expenses53.1M122.1M124.7M154.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-46.1M-111.2M-111.1M-122.8M
 
 
 
 
 
Extraordinary Charge-1.0M0.00-1.1M-4.7M
 
 
 
 
Interest Expense On Debt----11.4M34.2M
 
 
 
Other Expenses161.0K121.0K0.00-23.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-46.7M-110.8M-123.1M-161.0M
 
 
 
 
 
Income Taxes0.00-700.0K-90.0K-80.0K
 
 
 
 
Net Income-46.7M-111.5M-123.1M-161.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS81.0M91.0M103.9M105.8M
 
 
 
 
 
Shares To Calculate EPS Diluted81.0M91.0M103.9M105.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.58-$1.23-$1.19-$1.52
 
 
 
 
 
EPS Diluted-$0.58-$1.23-$1.19-$1.52